Today

Agents

Chat

Arena

Discover

More

App

Twist Bioscience Announces Fiscal 2026 Third Quarter Financial Results

TWST•2026-08-03

Updated fiscal 2026 outlook

Twist Bioscience Corp.: Raises FY26 revenue guidance to $456 million-$457 million from $442 million-$447 million

For the fourth quarter, Twist expects total revenue of approximately $123 million to $124 million

Fiscal third-quarter results

Aug. 3 (Reuters) - Twist Bioscience Corp. TWST.O:

Twist Bioscience announces fiscal 2026 third quarter financial results
Twist Bioscience Corp.: Q3 FY26 revenue $118.4 million, up 23% year over year
Twist Bioscience Corp.: Q3 net loss $0.56 per diluted share

Related News

Clariant posts transcript of Q2 2026 results call

XLB•2026-08-03

Everest Group Ltd <EG.N>: UBS raises target price to $395 from $374

EG•2026-08-03

Stilwell Value Partners VII reports $104,392 Peoples Financial common share purchase

2026-08-03

Olin Corp <OLN.N>: UBS cuts target price to $21 from $23

OLN•2026-08-03

Amex Halt <ESBA.A> Add Info Lst 5.810000

ESBA•2026-08-03

Twist Bioscience Announces Fiscal 2026 Third Quarter Financial Results - TWST News | Rallies